ライフサイエンスコーパス: were compared between

1 gnal differences in response to SS and neutral stimuli (NS) were compared between 14 drug-free PI patients and 18 good sl

2 Graft survival and infections were compared between 2 groups.

3 The expression levels of genes transcribed in antennae were compared between 5(th) instar larvae, and female and mal

4 f anomalous experiences induced by three experimental tasks were compared between all groups.

5 ity of glaucoma control vs time postoperatively, and values were compared between angle surgery cohorts using Wilcoxon si

6 Mean lesion attenuation values and material densities were compared between benign and malignant renal lesions by u

7 ar and mean change in logMAR VA between baseline and 1 year were compared between drug types.

8 Propensity-weighted mean domain scores were compared between each treatment group vs active surveill

9 operative functional and anatomic results at 1 and 6 months were compared between glaucomatous and nonglaucomatous eyes.

10 CSF tau levels were compared between groups and correlated with digital hist

11 Serum Cr levels and GFRs for each time period were compared between groups by using hierarchic regressions

12 GP:T and DN:P SI ratios were compared between groups by using the analysis of varianc

13 Levels of cytokines and chemokines were compared between groups using multivariate logistic regr

14 Two-year outcomes were compared between groups using univariate and multivariab

15 ctional connectivity during processing of emotional stimuli were compared between groups, and differences were explored f

16 ne parameter estimates for the dynamic causal models, which were compared between groups.

17 emographics, geography, and hospital and physician presence were compared between HSAs.

18 Mortality, complications, and prolonged length of stay were compared between IMG and USMG surgeon status using optim

19 Urinary Escherichia coli antibiograms were compared between institutional versus ED and among ED pa

20 Rates of AKI, emergent dialysis, and mortality were compared between IOCM and noncontrast groups.

21 hen crestal bone changes from implant placement to 6 months were compared between MACH and GBAE groups, no significant di

22 d by histology and immunohistochemistry, and transcriptomes were compared between mice that did or did not express KLF5.

23 MR imaging features were compared between patients and control subjects by using

24 Clinical outcomes were compared between patients displaying greater than (n=152

25 dial infarction, stroke, and heart failure hospitalization, were compared between patients who adhered to serial evaluati

26 eak systolic velocity (PSV) and resistive index (RI) values were compared between patients with and patients without appe

27 edication costs) and utilization (visits, hospitalizations) were compared between patients with and without IBD, and betw

28 and positive affect), and personality (Type D personality) were compared between patients with NOCAD and an age- and sex

29 Quantitative parameters were compared between patients with pCR and those with non-pC

30 Results of logistic regression and areas under the curve were compared between PI-RADS versions 1 and 2.

31 Angiogenesis factor levels were compared between responders and nonresponders by mRECIST

32 Hemodynamic, physiological, and behavioral parameters were compared between sated and abstinent scans.

33 The occurrence of these "Motifs" were compared between sleeps preceding the waking period ("Sl

34 Performance measures were compared between studies with low BPE (mild or minimal)

35 Rates were compared between study interventions (prednisone, mitoxa

36 , and spectral-domain OCT were obtained, and these findings were compared between the 2 groups.

37 nd 2 OCPs measured in banked second-trimester serum samples were compared between the diagnostic groups.

38 rimary tumour (SUVmax-T) and NT ratios (SUVmax-LN/SUVmax-T) were compared between the groups.

39 Outcomes - assessed 8 to 42 days after delivery - were compared between the intervention group and the control

40 mma-aminobutyric acid immunostaining of the medulla and LOX were compared between the praying mantis and two related poly

41 ying a common amplitude threshold and burst characteristics were compared between the two drug conditions.

42 rences between the right and left branches (ADC, thickness) were compared between the two groups.

43 inimal inhibitory concentration for Pseudomonas aeruginosa) were compared between the two groups.

44 IRS and fMRI was only present when data from the same story were compared between the two modalities and vanished when da

45 The anatomic results were compared between these 2 groups.

46 System performance and clinical imaging were compared between this next-generation system and other c

47 Patient-reported outcomes were compared between those who received and did not receive

48 either increasing border activity or retinitis progression) were compared between those with and without immune recovery.

49 Protein changes in the blood after 1 month of treatment were compared between tofacitinib (10 mg two times a day) and

50 Within-trial resource use and cost were compared between treatments, using externally derived US